The use of indocyanine green fluorescence imaging in preventing postoperative bile leakage of the hepaticojejunostomy in robot-assisted pancreatic surgery

Gijsen, Anton F.; Vries, Rachelle de; Lips, Daan J.

doi:10.1016/j.hpb.2021.08.363

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Future use of and indications for ICG fluorescence imaging will no doubt continue to evolve. Intravenous ICG injection could potentially be used to assess newly‐made hepaticojejunostomies for bile leakage, allowing for prompt revisions of anastomotic leakages 50 . Parallelling the rise of novel targeted cancer immunotherapies, next generation dyes may be conjugated to tumour‐specific antibodies.…”

Section: Discussionmentioning

confidence: 99%

“…Intravenous ICG injection could potentially be used to assess newly‐made hepaticojejunostomies for bile leakage, allowing for prompt revisions of anastomotic leakages. 50 Parallelling the rise of novel targeted cancer immunotherapies, next generation dyes may be conjugated to tumour‐specific antibodies. This modality promises to provide increased selectivity and allow for dual‐channel imaging when used in conjugation with classic ICG.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Indocyanine green (ICG) fluorescence in robotic hepatobiliary surgery: A systematic review

Potharazu

Gangemi

2022

Robotics Computer Surgery

View full text Add to dashboard Cite

Background: Indocyanine green fluorescence (ICG-F) stains hepatic tumours and delineates vascular and biliary structures in real-time. We detail the efficacy of ICG-F in robotic hepatobiliary surgery.Methods: PubMed, EMBASE, Web of Science, and Cochrane Central were searched for original articles and meta-analyses detailing the outcomes of ICG-F in robotic hepatobiliary surgery.Results: 214 abstracts were reviewed; 16 studies are presented. One singleinstitution study reported ICG-F in robotic right hepatectomy reduced postoperative bile leakage (0% vs. 12%, p = 0.023), R1 resection (0% vs. 16%, p = 0.019), and readmission (p = 0.023) without prolonging operative time (288 vs. 272 min, p = 0.778). Improved visualisation aided in attainment of R0 resection in partial hepatectomies and radical gallbladder adenocarcinoma resections. Fewer ICG-Faided robotic cholecystectomies were converted to open procedure compared to laparoscopic cholecystectomies (2.1% vs. 8.9%, p = 0.03; 0.15% vs. 2.6%, p < 0.001).Conclusions: ICG-F improves clinical outcomes in robotic hepatobiliary surgery without prolonging operative time. There is an opportunity to standardise ICG administration protocols, especially for hepatectomies.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%